A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

Clinical trial NCT00587457 · TERMINATED

Trial details

NCT number: NCT00587457
Sponsor: MedImmune LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphoma, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Small Lymphocytic Lymphoma, Moxetumomab Pasudotox

Start date: 2007-03-07
Primary completion: 2008-04-07
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.